Skip to main content

Table 9 Permanent trial drug discontinuation

From: A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial

Point of treatment discontinuation

Group A N=

Group B

N=

Total

N=

Baseline (n, %)

   

Week 1 (n, %)

   

Week 2 (n, %)

   

Week 3 (n, %)

   

Week 4 (n, %)

   

Week 5 (n, %)

   

Week 6 (n, %)

   

Week 7 (n, %)

   

Week 8 (n, %)